GlassScriptPhysician profile
Sarah Fraser
NPI 1053051516
$478.59
in general payments reported to CMS, 2019-2025
13 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $55.89 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $155.98 | 2025 | |
| Pfizer INC. | $49.61 | 2025 | |
| Abbvie INC. | $43.07 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.51 | 2025 | |
| Astellas Pharma US INC | $26.70 | 2025 | Veozah |
| Novo Nordisk INC | $23.87 | 2025 | Ozempic |
| Qol Medical, LLC | $23.55 | 2023 | Sucraid |
| Exact Sciences Corporation | $21.92 | 2025 | The Cologuard Plus Collection Kit |
| Sonex Health, INC. | $21.85 | 2025 | Sx-One Microknife |
| Novartis Pharmaceuticals Corporation | $21.66 | 2025 | |
| Sage Therapeutics, LLC | $17.66 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $17.66 | 2025 | Qelbree |
| Medtronic, INC. | $13.55 | 2023 | Linq II |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Fraser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.